Lucid Diagnostics Inc.

US$0.40As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:LUCDHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (47.35%)
Div yield —
ROE (556.27%)
Medical Devices
Beta (5Y) 1.16
PE TTM —
TSR TTM (67.11%)
Mkt cap US$76.00M
ROIC (88.92%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.407
2.18%
(81.14%)
Hold 3|7|12|8|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
0.47%
3.73%
5.38%
9.30%
Revenue$M
5.379
5.654
5.804
5.765
9.05%
9.65%
6.40%
8.17%
Peers (US$76.00M)
Cap (US$)
PE
76.30M
—
76.16M
23.43x
Capital
TTM
5Y
10Y
Leveragex
0.293
0.709
0.537
EBIT/Intx
0.482
0.746
0.643
Own earn%
52.93
(90.35)
(33.03)
Sh yield%
16.89
27.85
25.78
Owners
Insiders/Inst%
6.30
57.10
Short interest%
3.24
SBC / revenue%
3.93
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
14–20
$1 testx
0.5
Incr. ROIC%
2